Estrella Immunopharma, Inc. ESLA Q2 2025 earnings
Reported August 11, 2025 · Before market open
EPS-$0.15Miss by $0.08
EPS estimate-$0.07
Next report
Sep 2, 2026 (in a month)EPS estimate-$0.09
Versus estimates
Diluted EPS
Ask the moment Estrella Immunopharma, Inc. reports.
Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.
Connect your AI
Claude
Questions, answered.
- When did Estrella Immunopharma, Inc. report Q2 2025 earnings?
- Estrella Immunopharma, Inc. (ESLA) reported Q2 2025 earnings on August 11, 2025 before market open.
- What were Estrella Immunopharma, Inc.'s Q2 2025 revenue and EPS?
- Estrella Immunopharma, Inc. reported eps of $-0.15 for Q2 2025.
- Did Estrella Immunopharma, Inc. beat estimates in Q2 2025?
- EPS missed the consensus estimate of $-0.07 by $0.08.
- How did Estrella Immunopharma, Inc.'s Q2 2025 results compare year-over-year?
- Compared to the same quarter a year prior, eps declined 15.4% from $-0.13.
- Where can I find Estrella Immunopharma, Inc.'s Q2 2025 SEC filings?
- You can read the 10-Q periodic report (0001213900-25-074567) directly on SEC EDGAR. The filing index links above go to sec.gov.